OMSCX
Price
$22.91
Change
-$0.29 (-1.25%)
Updated
Jun 13 closing price
Net Assets
1.51B
VTSMX
Price
$142.86
Change
-$1.69 (-1.17%)
Updated
Jun 13 closing price
Net Assets
1.82T
Interact to see
Advertisement

OMSCX vs VTSMX

Header iconOMSCX vs VTSMX Comparison
Open Charts OMSCX vs VTSMXBanner chart's image
Invesco Main Street All Cap C
Price$22.91
Change-$0.29 (-1.25%)
VolumeN/A
Net Assets1.51B
Vanguard Total Stock Mkt Idx I
Price$142.86
Change-$1.69 (-1.17%)
VolumeN/A
Net Assets1.82T
OMSCX vs VTSMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OMSCX vs. VTSMX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OMSCX is a Buy and VTSMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.82T vs. OMSCX (1.51B). VTSMX pays higher dividends than OMSCX: VTSMX (1.18) vs OMSCX (0.12). OMSCX was incepted earlier than VTSMX: OMSCX (25 years) vs VTSMX (33 years). OMSCX (1.79) is less costly to investors than VTSMX (0.14). OMSCX is a more actively managed with annual turnover of: 54.00 vs. VTSMX (2.00). OMSCX has a lower initial minimum investment than VTSMX: OMSCX (1000) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 10.06 vs. OMSCX (1.76). VTSMX return over 5 years is better than : 91.36 vs. OMSCX (37.73).
OMSCXVTSMXOMSCX / VTSMX
Total Expense Ratio1.790.141,279%
Annual Report Gross Expense Ratio1.790.141,279%
Fund Existence25 years33 years-
Gain YTD2.9201.349217%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.51B1.82T0%
Annual Yield % from dividends0.121.1810%
Returns for 1 year1.7610.0618%
Returns for 3 years34.9357.5961%
Returns for 5 years37.7391.3641%
Returns for 10 years22.62178.9213%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NTR62.892.45
+4.05%
Nutrien Ltd
ELEV0.38N/A
+0.39%
Elevation Oncology
AKBA3.56-0.09
-2.47%
Akebia Therapeutics
MHO107.02-3.34
-3.03%
M/I Homes
AXTI2.16-0.19
-8.09%
AXT